Your browser doesn't support javascript.
loading
Late-stage modification of peptides and proteins at cysteine with diaryliodonium salts.
Byrne, Stephen A; Bedding, Max J; Corcilius, Leo; Ford, Daniel J; Zhong, Yichen; Franck, Charlotte; Larance, Mark; Mackay, Joel P; Payne, Richard J.
Afiliação
  • Byrne SA; School of Chemistry, The University of Sydney Sydney NSW 2006 Australia richard.payne@sydney.edu.au.
  • Bedding MJ; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney Sydney NSW 2006 Australia.
  • Corcilius L; School of Chemistry, The University of Sydney Sydney NSW 2006 Australia richard.payne@sydney.edu.au.
  • Ford DJ; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney Sydney NSW 2006 Australia.
  • Zhong Y; School of Chemistry, The University of Sydney Sydney NSW 2006 Australia richard.payne@sydney.edu.au.
  • Franck C; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney Sydney NSW 2006 Australia.
  • Larance M; School of Chemistry, The University of Sydney Sydney NSW 2006 Australia richard.payne@sydney.edu.au.
  • Mackay JP; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney Sydney NSW 2006 Australia.
  • Payne RJ; School of Life and Environmental Sciences, The University of Sydney Sydney NSW 2006 Australia.
Chem Sci ; 12(42): 14159-14166, 2021 Nov 03.
Article em En | MEDLINE | ID: mdl-34760200
ABSTRACT
The modification of peptides and proteins has emerged as a powerful means to efficiently prepare high value bioconjugates for a range of applications in chemical biology and for the development of next-generation therapeutics. Herein, we report a novel method for the chemoselective late-stage modification of peptides and proteins at cysteine in aqueous buffer with suitably functionalised diaryliodonium salts, furnishing stable thioether-linked synthetic conjugates. The power of this new platform is showcased through the late-stage modification of the affibody zEGFR and the histone protein H2A.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Chem Sci Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Chem Sci Ano de publicação: 2021 Tipo de documento: Article